Questcor Pharmaceuticals (QCOR)
Add to Watchlists Create an Alert
34.24
-1.05 -2.98%
NASDAQ
May 24, 12:37PM
BATS Real time
Currency in USD
Questcor Pharmaceuticals Revenue Quarterly YoY Growth:
40.81% for March 31, 2013Questcor Pharmaceuticals Historical Revenue Quarterly YoY Growth Data
Pro Data Export
Dates:
to
There is no data for the selected date range.
| Data for this Date Range | |
|---|---|
| March 31, 2013 | 40.81% |
| Dec. 31, 2012 | 112.5% |
| Sept. 30, 2012 | 134.6% |
| June 30, 2012 | 144.6% |
| March 31, 2012 | 160.5% |
| Dec. 31, 2011 | 157.8% |
| Sept. 30, 2011 | 91.28% |
| June 30, 2011 | 62.38% |
| March 31, 2011 | 40.35% |
| Dec. 31, 2010 | 13.09% |
| Sept. 30, 2010 | 125.8% |
| June 30, 2010 | 12.07% |
| March 31, 2010 | 12.64% |
| Dec. 31, 2009 | -4.12% |
| Sept. 30, 2009 | -42.76% |
| June 30, 2009 | 1.48% |
| March 31, 2009 | 21.78% |
| Dec. 31, 2008 | -0.35% |
| Sept. 30, 2008 | 63.41% |
| June 30, 2008 | 500.8% |
| March 31, 2008 | Go Pro |
| Dec. 31, 2007 | Go Pro |
| Sept. 30, 2007 | Go Pro |
| June 30, 2007 | Go Pro |
| March 31, 2007 | Go Pro |
| Dec. 31, 2006 | Go Pro |
| Sept. 30, 2006 | Go Pro |
| June 30, 2006 | Go Pro |
| March 31, 2006 | Go Pro |
| Dec. 31, 2005 | Go Pro |
| Sept. 30, 2005 | Go Pro |
| June 30, 2005 | Go Pro |
| March 31, 2005 | Go Pro |
| Dec. 31, 2004 | Go Pro |
| Sept. 30, 2004 | Go Pro |
| June 30, 2004 | Go Pro |
| March 31, 2004 | Go Pro |
| Dec. 31, 2003 | Go Pro |
| Sept. 30, 2003 | Go Pro |
| June 30, 2003 | Go Pro |
| March 31, 2003 | Go Pro |
| Dec. 31, 2002 | Go Pro |
| Sept. 30, 2002 | Go Pro |
| June 30, 2002 | Go Pro |
| March 31, 2002 | Go Pro |
| Dec. 31, 2001 | Go Pro |
| Sept. 30, 2001 | Go Pro |
| June 30, 2001 | Go Pro |
| March 31, 2001 | Go Pro |
| Dec. 31, 2000 | Go Pro |
About Revenue Growth
Revenue growth illustrates sales increases/decreases over time. It is used to measure how fast a business is expanding. More valuable than a snapshot of revenue, revenue growth helps investors identify trends in order to gauge revenue growth over time.
If a company generated $75 billion in revenue during 2008 and $100 billion in revenue during 2009, the company experienced roughly a ($100 billion/$75 billion)-1 = %33 increase in revenue.
Learn More
QCOR Revenue Quarterly YoY Growth Benchmarks
| Companies | |
|---|---|
| Theravance | -98.94% |
| Infinity Pharmaceuticals | -100.0% |
| Synageva BioPharma | 113.5% |
QCOR Revenue Quarterly YoY Growth Rankings
| Overall |
93rd percentile 485 of 8009 |
| Sector |
87th percentile 87 of 687 in Healthcare |
| Industry |
84th percentile 38 of 248 in Biotechnology |
QCOR Revenue Quarterly YoY Growth Range, Past 5 Years
| Minimum | -42.76% | Sep 2009 |
| Maximum | 500.8% | Jun 2008 |
| Average | 82.44% |
